Safe Orthopaedics(GB:0RAA)
€188,520.000.00 (0.00%)
GB:0RAA
Safe Orthopaedics financials statements
€188,520.00
At close:0.00 (0.00%)
Safe Orthopaedics (0RAA) Ratios
0 Followers
Safe Orthopaedics Ratios
GB:0RAA's free cash flow for Q4 2024 was €-2.14B. For the 2024 fiscal year, GB:0RAA's free cash flow was decreased by €-88.00M and operating cash flow was €-2.05B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.41 | ― | 0.03 | 0.74 | 0.91 |
| Quick Ratio | 0.26 | ― | 0.02 | 0.38 | 0.51 |
| Cash Ratio | 0.02 | ― | 0.00 | 0.02 | 0.10 |
| Solvency Ratio | -0.16 | ― | -0.72 | -0.34 | -0.40 |
| Operating Cash Flow Ratio | -0.10 | ― | -0.00 | -0.44 | -0.76 |
| Short-Term Operating Cash Flow Coverage | -0.16 | ― | -0.00 | -1.27 | -1.91 |
| Net Current Asset Value | € -14.08M | ― | € -271.82M | € -8.54M | € -6.24M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.14 | ― | 3.48 | 0.60 | 0.60 |
| Debt-to-Equity Ratio | -1.26 | ― | -1.34 | -7.73 | 22.26 |
| Debt-to-Capital Ratio | 4.78 | ― | 3.94 | 1.15 | 0.96 |
| Long-Term Debt-to-Capital Ratio | 0.00 | ― | -0.01 | 1.59 | 0.93 |
| Financial Leverage Ratio | -1.11 | ― | -0.39 | -12.91 | 37.39 |
| Debt Service Coverage Ratio | -0.24 | ― | -0.75 | -1.21 | -1.23 |
| Interest Coverage Ratio | 0.00 | ― | -36.60 | -16.79 | -11.88 |
| Debt to Market Cap | 40.22 | ― | 72.63 | 0.01 | 0.00 |
| Interest Debt Per Share | 74.60 | ― | 3576050.36 | 141408.47 | 131123.46 |
| Net Debt to EBITDA | -4.37 | ― | -1.01 | -1.70 | -1.53 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | ― | 74.41% | -74.36% | -126.04% |
| EBIT Margin | -64.81% | ― | -4666.06% | -112.76% | -133.29% |
| EBITDA Margin | -55.59% | ― | -4615.68% | -95.96% | -114.21% |
| Operating Profit Margin | -64.81% | ― | -137.31% | -101.72% | -166.49% |
| Pretax Profit Margin | 0.00% | ― | -4669.81% | -118.82% | -147.32% |
| Net Profit Margin | -75.93% | ― | -3536.04% | -118.84% | -147.32% |
| Continuous Operations Profit Margin | 0.00% | ― | -3536.04% | -118.84% | -147.32% |
| Net Income Per EBT | 0.00% | ― | 75.72% | 100.01% | 100.00% |
| EBT Per EBIT | 0.00% | ― | 3400.80% | 116.81% | 88.49% |
| Return on Assets (ROA) | -34.72% | ― | -263.64% | -42.17% | -45.09% |
| Return on Equity (ROE) | 38.39% | ― | 101.53% | 544.57% | -1685.68% |
| Return on Capital Employed (ROCE) | 39.62% | ― | 4.04% | -146.49% | -129.90% |
| Return on Invested Capital (ROIC) | 0.00% | ― | -8.50% | -67.12% | -80.52% |
| Return on Tangible Assets | -35.57% | ― | -263.68% | -47.91% | -61.78% |
| Earnings Yield | -1294.40% | ― | -5535.31% | -1.24% | -0.00% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.90 | ― | 2.58 | 2.01 | 1.28 |
| Payables Turnover | 0.00 | ― | 0.70 | 2.85 | 1.05 |
| Inventory Turnover | 0.00 | ― | 0.35 | 2.27 | 0.54 |
| Fixed Asset Turnover | 2.69 | ― | 1.63 | 1.11 | 1.00 |
| Asset Turnover | 0.46 | ― | 0.07 | 0.35 | 0.31 |
| Working Capital Turnover Ratio | -0.47 | ― | -0.04 | -2.94 | 5.14 |
| Cash Conversion Cycle | 192.44 | ― | 671.92 | 214.49 | 607.03 |
| Days of Sales Outstanding | 192.44 | ― | 141.48 | 181.60 | 284.61 |
| Days of Inventory Outstanding | 0.00 | ― | 1050.82 | 161.05 | 670.64 |
| Days of Payables Outstanding | 0.00 | ― | 520.38 | 128.16 | 348.22 |
| Operating Cycle | 192.44 | ― | 1192.29 | 342.65 | 955.25 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -11.12 | ― | -14967.02 | -75515.41 | -94553.02 |
| Free Cash Flow Per Share | -11.90 | ― | -15704.83 | -87360.42 | -121570.14 |
| Dividend Paid and CapEx Coverage Ratio | -14.38 | ― | -20.29 | -6.38 | -3.50 |
| Capital Expenditure Coverage Ratio | -14.38 | ― | -20.29 | -6.38 | -3.50 |
| Operating Cash Flow Coverage Ratio | -0.15 | ― | -0.00 | -0.55 | -0.77 |
| Operating Cash Flow to Sales Ratio | -0.37 | ― | -0.20 | -0.93 | -1.50 |
| Free Cash Flow Yield | -679.72% | ― | -32.12% | -1.12% | -0.00% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.08 | ― | -0.02 | -80.81 | -30080.98 |
| Price-to-Sales (P/S) Ratio | 0.06 | ― | 0.64 | 96.03 | 44315.48 |
| Price-to-Book (P/B) Ratio | -0.03 | ― | -0.02 | -440.05 | 507067.04 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.15 | ― | -3.11 | -88.94 | -22917.63 |
| Price-to-Operating Cash Flow Ratio | -0.16 | ― | -3.27 | -102.89 | -29466.01 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | ― | -0.00 | -21.18 | 300.93 |
| Enterprise Value Multiple | -4.47 | ― | -1.02 | -101.78 | -38804.20 |
| Enterprise Value | 13.43M | ― | 274.14M | 572.41M | 201.82B |
| EV to EBITDA | -4.47 | ― | -1.02 | -101.78 | -38804.20 |
| EV to Sales | 2.49 | ― | 47.18 | 97.66 | 44317.22 |
| EV to Free Cash Flow | -6.24 | ― | -229.98 | -90.46 | -22918.54 |
| EV to Operating Cash Flow | -6.67 | ― | -241.32 | -104.65 | -29467.17 |
| Tangible Book Value Per Share | -60.57 | ― | -2666184.72 | -44977.92 | -50016.88 |
| Shareholders’ Equity Per Share | -59.00 | ― | -2666066.14 | -17657.08 | 5494.54 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | ― | 0.24 | -0.00 | -0.00 |
| Revenue Per Share | 29.83 | ― | 76547.87 | 80913.31 | 62869.68 |
| Net Income Per Share | -22.65 | ― | -2706764.31 | -96154.45 | -92620.27 |
| Tax Burden | 0.00 | ― | 0.76 | 1.00 | 1.00 |
| Interest Burden | 0.00 | ― | 1.00 | 1.05 | 1.11 |
| Research & Development to Revenue | 0.00 | ― | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | ― | 0.05 | 0.05 | 2.03 |
| Stock-Based Compensation to Revenue | 0.00 | ― | 0.01 | 0.00 | 0.00 |
| Income Quality | 0.43 | ― | 0.01 | 0.79 | 1.02 |
Currency in EUR
